Diana V Do

Summary

Publications

  1. ncbi Reversible cortical blindness in preeclampsia
    Diana V Do
    Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Am J Ophthalmol 134:916-8. 2002
  2. doi Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study
    Quan Dong Nguyen
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 117:2146-51. 2010
  3. ncbi Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment
    Diana V Do
    Wilmer Eye Institute, The Johns Hopkins University School of Medicine, 600 N Wolfe St, Baltimore, MD 21287, USA
    JAMA Ophthalmol 131:139-45. 2013
  4. pmc Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion
    Raafay Sophie
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    Am J Ophthalmol 156:693-705. 2013
  5. pmc Topical mecamylamine for diabetic macular edema
    Peter A Campochiaro
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    Am J Ophthalmol 149:839-51.e1. 2010
  6. ncbi Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction
    Diana V Do
    Retina Division, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Retina 27:552-6. 2007
  7. doi Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study
    Diana V Do
    Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 119:771-8. 2012
  8. doi Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes
    Peter A Campochiaro
    The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    Ophthalmology 117:2387-2394.e1-5. 2010
  9. ncbi Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema
    Jithin Yohannan
    Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 120:1254-61. 2013
  10. doi One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema
    Diana V Do
    Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 119:1658-65. 2012

Collaborators

Detail Information

Publications56

  1. ncbi Reversible cortical blindness in preeclampsia
    Diana V Do
    Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Am J Ophthalmol 134:916-8. 2002
    ..To report the clinical course and magnetic resonance imaging (MRI) findings in a 28-year-old woman with preeclampsia and reversible cortical blindness...
  2. doi Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study
    Quan Dong Nguyen
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 117:2146-51. 2010
    ..To determine the long-term effects of ranibizumab (RBZ) in patients with diabetic macular edema (DME)...
  3. ncbi Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment
    Diana V Do
    Wilmer Eye Institute, The Johns Hopkins University School of Medicine, 600 N Wolfe St, Baltimore, MD 21287, USA
    JAMA Ophthalmol 131:139-45. 2013
    ..To assess the benefit of increased follow-up and treatment with ranibizumab between months 24 and 36 in the Ranibizumab for Edema of the Macula in Diabetes (READ-2) Study...
  4. pmc Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion
    Raafay Sophie
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    Am J Ophthalmol 156:693-705. 2013
    ..To determine the percentage of ranibizumab-treated patients with retinal vein occlusion (RVO) who had resolution of edema for at least 6 months after the last injection, along with factors and outcomes that correlate with resolution...
  5. pmc Topical mecamylamine for diabetic macular edema
    Peter A Campochiaro
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    Am J Ophthalmol 149:839-51.e1. 2010
    ..The safety and bioactivity of topical mecamylamine, an antagonist of nACh receptors, was tested in patients with diabetic macular edema...
  6. ncbi Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction
    Diana V Do
    Retina Division, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Retina 27:552-6. 2007
    ....
  7. doi Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study
    Diana V Do
    Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 119:771-8. 2012
    ....
  8. doi Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes
    Peter A Campochiaro
    The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    Ophthalmology 117:2387-2394.e1-5. 2010
    ..To determine the long-term effects of intraocular antagonism of vascular endothelial growth factor (VEGF) in patients with macular edema caused by retinal vein occlusions (RVOs)...
  9. ncbi Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema
    Jithin Yohannan
    Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 120:1254-61. 2013
    ..To evaluate the relationship between retinal sensitivity and the photoreceptor inner segment/outer segment (IS/OS) layer status in patients with diabetic macular edema (DME)...
  10. doi One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema
    Diana V Do
    Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 119:1658-65. 2012
    ..To compare different doses and dosing regimens of Vascular Endothelial Growth Factor (VEGF) Trap-Eye with laser photocoagulation in eyes with diabetic macular edema (DME)...
  11. doi Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert
    Peter A Campochiaro
    The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    Ophthalmology 117:1393-9.e3. 2010
    ..To compare Iluvien intravitreal inserts that release 0.2 or 0.5 microg/day of fluocinolone acetonide (FA) in patients with diabetic macular edema (DME)...
  12. ncbi Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study
    Quan Dong Nguyen
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    Ophthalmology 116:2175-81.e1. 2009
    ..To compare ranibizumab with focal/grid laser or a combination of both in diabetic macular edema (DME)...
  13. ncbi Monitoring ocular drug therapy by analysis of aqueous samples
    Peter A Campochiaro
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 116:2158-64. 2009
    ..To assess the value of sampling aqueous humor for measurement of potential molecular targets and for pharmacokinetic analysis...
  14. doi Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration
    Quan Dong Nguyen
    Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    J Ocul Pharmacol Ther 28:581-8. 2012
    ..To determine bioactivity and duration of effect of intravitreal aflibercept injection (also known as vascular endothelial growth factor Trap-Eye) for neovascular age-related macular degeneration (AMD)...
  15. pmc Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin A-4 phosphate
    Mohamed A Ibrahim
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    BMC Pharmacol Toxicol 14:7. 2013
    ..This study was designed to assess the safety, tolerability, and efficacy of intravenous infusion of CA4P in patients with neovascular age-related macular degeneration (AMD)...
  16. ncbi Progression of macular ischemia following intravitreal bevacizumab
    E Jason Sabet-Peyman
    Retina Division, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ophthalmic Surg Lasers Imaging 40:316-8. 2009
    ..One week after treatment, she presented with central scotoma and fluorescein angiography revealed increased parafoveal capillary dropout and progressive macular ischemia in the treated eye...
  17. doi Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator
    Peter A Campochiaro
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    Mol Ther 16:791-9. 2008
    ....
  18. pmc Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography
    Roomasa Channa
    Retinal Imaging Research and Reading Center RIRRC, Wilmer Eye Institute, Johns Hopkins University, 600 North Wolfe Street, Maumenee 745, Baltimore, MD, 21287, USA
    J Ophthalmic Inflamm Infect 2:113-20. 2012
    ..Spectral domain optical coherence tomography (SD-OCT) allows detailed visualization of retinal and choroidal structures. We aimed to describe the retinal changes on SD-OCT associated with PIC lesions localized in the macula...
  19. pmc Comparison of time domain and spectral domain optical coherence tomography in measurement of macular thickness in macular edema secondary to diabetic retinopathy and retinal vein occlusion
    Elham Hatef
    Retinal Imaging Research and Reading Center RIRRC, Wilmer Eye Institute, Johns Hopkins Hospital, 600 North Wolfe Street, Maumenee 745, Baltimore, MD 21287, USA
    J Ophthalmol 2012:354783. 2012
    ..Conclusion. There are low agreements among interdevice measurements. However, intraclass repeatability is high in both TD and SD-OCT devices...
  20. doi Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy
    Peykan Turkcuoglu
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ocul Immunol Inflamm 19:286-92. 2011
    ..To compare the frequencies of attacks before and after immunomodulatory therapy (IMT) with mycophenolate mofetil (MMF) in recurrent punctate inner choroidopathy (PIC) and to report fundus autofluorescence (FAF) findings...
  21. doi The relationship between macular sensitivity and retinal thickness in eyes with diabetic macular edema
    Elham Hatef
    Retinal Imaging Research and Reading Center RIRRC, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Am J Ophthalmol 152:400-405.e2. 2011
    ..To investigate relationship between macular sensitivity and retinal thickness in diabetic macular edema (DME)...
  22. pmc The impact of optical coherence tomography on surgical decision making in epiretinal membrane and vitreomacular traction
    Diana V Do
    Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Trans Am Ophthalmol Soc 104:161-6. 2006
    ....
  23. ncbi Cystoid macular edema responds to intravitreal triamcinolone and rebounds after intravitreal bevacizumab
    E Jason Sabet-Peyman
    Retina Division, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Ophthalmic Surg Lasers Imaging 40:413-5. 2009
    ..Further studies are needed to evaluate the pathogenesis of cystoid macular edema and determine whether vascular endothelial growth factor blockade should be included in treatment modalities for this condition...
  24. ncbi A randomized, double-masked controlled clinical trial of Sandostatin long-acting release depot in patients with postsurgical cystoid macular edema
    Syed Mahmood Ali Shah
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Retina 30:160-6. 2010
    ..The purpose of this study was to evaluate the safety and efficacy of octreotide, a somatostatin analog, for treatment of postsurgical cystoid macular edema...
  25. ncbi A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration
    Quan Dong Nguyen
    Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland 21287 9277, USA
    Ophthalmology 116:2141-8.e1. 2009
    ....
  26. doi Putting theories and results into practice: managing cases
    Quan Dong Nguyen
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ophthalmology 120:S16-22. 2013
    ....
  27. doi Sclerochoroidal calcifications imaged using enhanced depth imaging optical coherence tomography
    Jithin Yohannan
    Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ocul Immunol Inflamm 20:190-2. 2012
    ..To report a case of sclerochoroidal calcifications and describe the appearance of these lesions using optical coherence tomography with enhanced depth imaging (EDI-OCT) technology...
  28. ncbi Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration
    Quan Dong Nguyen
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Am J Ophthalmol 145:257-266. 2008
    ..To investigate the safety, tolerability, and bioactivity of intravenous infusions of bevacizumab in patients with choroidal neovascularization (CNV) attributable to causes other than age-related macular degeneration...
  29. ncbi Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration
    Margaret A Chang
    Retina Division and Dana Center for Preventive Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Retina 30:1171-6. 2010
    ..To determine the safety and effect of ranibizumab on predominantly hemorrhagic choroidal neovascular lesions due to age-related macular degeneration...
  30. pmc Therapies for neovascular age-related macular degeneration: current approaches and pharmacologic agents in development
    Mostafa Hanout
    Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA Ocular Imaging Research and Reading Center, Stanley M Truhlsen Eye Institute, University of Nebraska Medical Center, 3902 Leavenworth Street, Omaha, NE, USA
    Biomed Res Int 2013:830837. 2013
    ..The purpose of this paper is to briefly review the available treatment modalities for neovascular AMD and then focus on promising new therapies that are currently in various stages of development. ..
  31. pmc Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis
    Henry A Leder
    Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins Hospital, Johns Hopkins University, Maumenee 745, 600 North Wolfe Street, Baltimore, MD, 21287, USA
    J Ophthalmic Inflamm Infect 3:30. 2013
    ..The secondary outcome was the percentage of patients whose disease was determined to be active based on each modality...
  32. doi The role of biologic agents in the management of non-infectious uveitis
    Jangwon Heo
    Johns Hopkins University School of Medicine, Wilmer Eye Institute, Johns Hopkins Hospital, Retinal Imaging Research and Reading Center, 600 North Wolfe Street, Maumenee 745, Baltimore, MD 21287, USA
    Expert Opin Biol Ther 12:995-1008. 2012
    ..Due to the potential grave consequences of the disease process, it is important to assess the various therapeutic options available for treating uveitis, and their outcomes...
  33. pmc Macular sensitivity and fixation patterns in normal eyes and eyes with uveitis with and without macular edema
    Yasir J Sepah
    Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Ophthalmic Inflamm Infect 2:65-73. 2012
    ..This study aims to investigate the relationship between macular sensitivity and thickness in eyes with uveitic macular edema (UME)...
  34. doi Intercellular adhesion molecule inhibitors as potential therapy for refractory uveitic macular edema
    Jianmin Wang
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Ocul Immunol Inflamm 18:395-8. 2010
    ..To describe the bioactivity of an intercellular adhesion molecule inhibitor (efalizumab) in a patient with refractory uveitic macular edema...
  35. doi Wide-field retinal imaging in the management of noninfectious posterior uveitis
    John Peter Campbell
    Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA
    Am J Ophthalmol 154:908-911.e2. 2012
    ..To determine whether the use of ultra wide-field imaging changes the management or determination of disease activity in patients with noninfectious posterior uveitis...
  36. doi Use of retinal procedures in medicare beneficiaries from 1997 to 2007
    Pradeep Y Ramulu
    Wilmer Eye Institute, Johns HopkinsUniversity, Baltimore, Maryland, USA
    Arch Ophthalmol 128:1335-40. 2010
    ..To observe how the treatment of retinal conditions changed over the preceding decade...
  37. pmc Retinal thickness analysis by race, gender, and age using Stratus OCT
    Amir H Kashani
    Wilmer Eye Institute and Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland 21287, USA
    Am J Ophthalmol 149:496-502.e1. 2010
    ..To detect differences in retinal thickness among patients of different race, gender, and age using Stratus OCT...
  38. doi The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema
    Diana V Do
    Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland, USA
    Ophthalmology 118:1819-26. 2011
    ..To determine whether different doses and dosing regimens of intravitreal vascular endothelial growth factor (VEGF) Trap-Eye are superior to focal/grid photocoagulation in eyes with diabetic macular edema (DME)...
  39. pmc Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study
    Quan Dong Nguyen
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Maumenee 745, Baltimore, MD, USA
    J Ophthalmic Inflamm Infect 3:32. 2013
    ..Thirty patients were enrolled and randomized in 1:1 ratio to receive either intravitreal injections of 352 μg sirolimus or subconjunctival injections of 1,320 μg at days 0, 60, and 120, with primary endpoint at month 6...
  40. ncbi New treatment options for noninfectious uveitis
    Millena Gomes Bittencourt
    Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA
    Dev Ophthalmol 51:134-61. 2012
    ..The new modes of drug delivery that we will describe in the index chapter include nanoparticles and iontophoresis...
  41. doi Atypical Bartonella hensalae chorioretinitis in an immunocompromised patient
    Sayjal J Patel
    School of Medicine, Wilmer Eye Institute, The Johns Hopkins University, Baltimore, Maryland, USA
    Ocul Immunol Inflamm 16:45-9. 2008
    ..To report an atypical case of chorioretinopathy in a patient with bilateral renal transplantations...
  42. pmc Driving habits in older patients with central vision loss
    Sabyasachi Sengupta
    Wilmer Eye Institute, The Johns Hopkins University, Baltimore, Maryland
    Ophthalmology 121:727-32. 2014
    ..To determine if central visual loss is associated with driving cessation, driving restriction, or other-driver preference...
  43. doi Implications of the comparisons of age-related macular degeneration treatments trials on clinical practice: what have we learned?
    Diana V Do
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ophthalmology 120:S8-10. 2013
    ..Discussion of Comparisons of Age-Related Macular Degeneration (AMD) Treatments Trials (CATT) results and the potential impact on neovascular AMD treatment...
  44. pmc Retinal optical coherence tomography manifestations of intraocular lymphoma
    Tin Yan Alvin Liu
    Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, 600 North Wolfe Street, Maumenee 745, Baltimore, MD, 21287, USA
    J Ophthalmic Inflamm Infect 2:215-8. 2012
    ..The index report describes a patient with intraocular lymphoma secondary to recurrent PCNSL and corresponding retinal findings on spectral domain optical coherence tomography (SD-OCT)...
  45. doi Nodular sclerochoroidopathy simulating choroidal malignancy
    Elham Hatef
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmic Surg Lasers Imaging 41:e1-5. 2010
    ..Nodular sclerochoroidopathy should be suspected in patients with subretinal and choroidal lesions and should be distinguished from choroidal neoplasm...
  46. pmc Importance of proper diagnosis for management: multifocal choroiditis mimicking ocular histoplasmosis syndrome
    Elham Hatef
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street Maumenee 745, Baltimore, MD, 21287, USA
    J Ophthalmic Inflamm Infect 1:55-63. 2011
    ..The study aims to evaluate a series of patients with initial diagnosis of ocular histoplasmosis syndrome (OHS) with progression and response to treatments consistent with multifocal choroiditis (MFC)...
  47. ncbi Persistent intermediate uveitis associated with latent manifestation of facial large B-cell non-Hodgkin lymphoma
    E Jason Sabet-Peyman
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Ocul Immunol Inflamm 17:322-4. 2009
    ..To report a case of intraocular non-Hodgkin lymphoma (NHL) manifesting as persistent intermediate uveitis, facial mass, and Bell palsy...
  48. ncbi A phase ia dose-escalation study of the anti-factor D monoclonal antibody fragment FCFD4514S in patients with geographic atrophy
    Diana V Do
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland California Retina Consultants and Research Foundation, Santa Barbara, California and Genentech, Inc, South San Francisco, California
    Retina 34:313-20. 2014
    ....
  49. pmc Choroidal neovascularization regression on fluorescein angiography after VEGF blockade
    Diana V Do
    Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, MD, USA
    Case Report Ophthalmol 3:384-8. 2012
    ..While optical coherence tomography is often the primary imaging modality used, fluorescein angiography (FA) can provide useful information on GA development after choroidal neovascularization (CNV) regression...
  50. pmc Isolated endogenous Nocardia endophthalmitis after immunosuppression
    Lisa Y Chen
    The Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Maumenee 745, Baltimore, MD, 21287, USA
    J Ophthalmic Inflamm Infect 2:141-3. 2012
    ..This study is aimed to report a case of endogenous Nocardia endophthalmitis in the setting of immunosuppression from chronic steroid use...
  51. ncbi Punctate inner choroidopathy: a survey analysis of 77 persons
    Adam T Gerstenblith
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 114:1201-4. 2007
    ..To evaluate the demographic and clinical features of punctate inner choroidopathy (PIC)...
  52. doi Recent trends in the management of rhegmatogenous retinal detachment
    Akrit Sodhi
    Wilmer Eye Institute, The Johns Hopkins Hospital, Baltimore, Maryland, USA
    Surv Ophthalmol 53:50-67. 2008
    ....
  53. doi Antiangiogenic approaches to age-related macular degeneration in the future
    Diana V Do
    The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ophthalmology 116:S24-6. 2009
    ..Data from these clinical trials will increase our knowledge of the pathogenesis of AMD and likely provide additions to the treatment armamentarium for improving vision and quality of life in patients with AMD...
  54. ncbi Vascular endothelial growth factor is a critical stimulus for diabetic macular edema
    Quan Dong Nguyen
    The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    Am J Ophthalmol 142:961-9. 2006
    ..The role of vascular endothelial growth factor (VEGF) in diabetic macular edema (DME) was tested with ranibizumab, a specific antagonist of VEGF...
  55. ncbi Large submacular hemorrhages after verteporfin therapy
    Diana V Do
    The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Am J Ophthalmol 137:558-60. 2004
    ....
  56. ncbi Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy
    Michael D Ober
    LuEsther T Mertz Retinal Research Center, Manhattan Eye, Ear and Throat Hospital, New York, New York, USA
    Ophthalmology 112:2088-94. 2005
    ..To report the use of photodynamic therapy with verteporfin as a treatment for patients with focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy (CSC)...